Whatman

www.whatman.com

Whatman, the world’s leading developer of high-end laboratory separation products. As a part of GE Healthcare, Whatman is creating a center of excellence in separations technology for the scientific community. Whether it’s a simple paper filter or technologies that help us understand the role of genes and proteins in disease treatments, our solutions enable scientists, engineers and medical staff to impact human lives every day – from the child who needs clean drinking water to the elderly woman who needs precisely the right amount of medication to the man undergoing cancer treatment. With this, we can promote Early Health to aid earlier diagnosis and treatment of diseases. No matter what industry you are in, or what type of research you are conducting, Whatman will help you achieve your goals and touch lives.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

8th International Conference on Bio-Sensing Technology

Conference

Related News

DNA SEQUENCING PRODUCTS MARKET DEMAND, RECENT TRENDS AND DEVELOPMENTS ANALYSIS 2025

Express Journal | April 13, 2020

As per the report, the DNA Sequencing Products market is predicted to gain significant returns while registering a lucrative annual growth rate during the foreseen time period. Exposing an enthralling outline of this DNA Sequencing Products industry, the report provides details about the complete valuation of the market, growth opportunities in the business verticals along with a detailed classification of the DNA Sequencing Products market. DNA Sequencing Products Market report is an extensive ...

Industry Outlook

SOMALOGIC PARTNERS WITH CITOGEN TO EXPAND AUTHORIZED SITE PROGRAM IN EUROPE

Globenewswire | June 13, 2023

SomaLogic, Inc., a leader in proteomics technology, announced their collaboration with Citogen, the Longwood Group’s customer services and support unit, to establish the company’s first authorized site in Spain. As part of the agreement, Citogen will offer the 7,000-plex SomaScan® Assay and provide SomaScan data to their customers in Southern Europe supporting biological research across an array of disciplines including clinical research, population health studies and nutri...

INRAE, EVOLUGATE ENTER OPTION LICENSE AGREEMENT TO ADVANCE PROBIOTICS TO MANAGE HUMAN CHOLESTEROL

Evolugate | May 28, 2020

INRAE, is pleased to announce that it has entered into an exclusive option license agreement with biotechnology company Evolugate of Gainesville, FL to optimize its probiotic to manage human hypercholesterolemia, a major risk factor for cardiovascular diseases.INRAE is the first worldwide research institute in agronomy. INRAE-Micalis has been investigating the human microbiome to identify microbes that can influence hypercholesterolemia. They have selected microbes that degrade or sequeste...

Cell and Gene Therapy

ORANGEWOOD PARTNERS MAKES STRATEGIC INVESTMENT IN BARRINGTON JAMES

Orangewood and Barrington James | October 06, 2022

Orangewood Partners a long-term focused private investment firm, announced an investment in Barrington James, a leading global recruitment firm that primarily serves the pharmaceutical, biotechnology and medical device sectors. Terms of the transaction were not disclosed. In partnering with Orangewood, Barrington James intends to enhance its global recruiting solutions, expand its client-service capabilities and support its ongoing commitment to developing and utilizing cutting-ed...